Fiscal Impact of HPV Prevention Strategies in Indonesia

Indonesia's economic analysis estimates the fiscal benefits of cervical cancer prevention for a cohort of 10,000,000 12-year-old females. The study calculates Net Present Value for vaccination, screening, and combined strategies, reporting reductions of 87,862 cervical cancer cases and 19,359 deaths.

Use Cases

• Compare Net Present Value (NPV) outcomes across HPV vaccination, cervical screening, and combined intervention strategies.
• Model the fiscal impact of reducing cervical cancer incidence by 87,862 cases and HPV-related mortality by 19,359 deaths.
• Analyze cost-benefit scenarios for government investment in cervical cancer prevention from a public health perspective.

Strengths

• Analysis is based on a defined cohort of 10,000,000 Indonesian females.
• Provides concrete outcome metrics, including 87,862 estimated cervical cancer cases prevented.
• Results include specific Net Present Value figures for three distinct prevention strategies.

Limitations

• Dataset structure and underlying raw data columns are not provided, limiting direct analytical use.
• Analysis is specific to the Indonesian context and a single cohort, limiting generalizability.
• The fiscal model's assumptions and input parameters are not detailed in the available description.

Provenance

Source

Dryad

Collection Method

A government-perspective quantitative analytic framework applied to assess Net Present Value of cervical cancer prevention.

Time Range

null

Freshness

null

Geography

Indonesia